BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36047900)

  • 1. Clinical Performance of the RealTi
    Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
    Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of BD Onclarity HPV Assay on Vaginal Self-Samples versus Cervical Samples Using the VALHUDES Protocol.
    Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Donders G; Doyen J; Tjalma W; De Sutter P; Peeters E; Vorsters A; Arbyn M
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2177-2184. PubMed ID: 36099441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
    Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
    J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
    Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Donders G; Doyen J; Tjalma W; De Sutter P; Vorsters A; Arbyn M
    J Mol Diagn; 2023 Sep; 25(9):702-708. PubMed ID: 37354994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
    Van Keer S; Peeters E; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Vorsters A; Arbyn M
    Gynecol Oncol; 2021 Sep; 162(3):575-583. PubMed ID: 34172287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
    Latsuzbaia A; Van Keer S; Vanden Broeck D; Weyers S; Donders G; De Sutter P; Tjalma W; Doyen J; Vorsters A; Arbyn M
    J Mol Diagn; 2023 Dec; 25(12):957-966. PubMed ID: 37865293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
    Arbyn M; Verdoodt F; Snijders PJ; Verhoef VM; Suonio E; Dillner L; Minozzi S; Bellisario C; Banzi R; Zhao FH; Hillemanns P; Anttila A
    Lancet Oncol; 2014 Feb; 15(2):172-83. PubMed ID: 24433684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.
    Van Keer S; Latsuzbaia A; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Arbyn M; Vorsters A
    J Clin Virol; 2022 Oct; 155():105271. PubMed ID: 36049283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.
    Avian A; Clemente N; Mauro E; Isidoro E; Di Napoli M; Dudine S; Del Fabro A; Morini S; Perin T; Giudici F; Cammisuli T; Foschi N; Mocenigo M; Montrone M; Modena C; Polenghi M; Puzzi L; Tomaic V; Valenti G; Sola R; Zanolla S; Vogrig E; Riva E; Angeletti S; Ciccozzi M; Castriciano S; Pachetti M; Petti M; Centonze S; Gerin D; Banks L; Marini B; Canzonieri V; Sopracordevole F; Zanconati F; Ippodrino R
    J Transl Med; 2022 May; 20(1):231. PubMed ID: 35581584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
    Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
    BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study.
    Ørnskov D; Jochumsen K; Steiner PH; Grunnet IM; Lykkebo AW; Waldstrøm M
    BMJ Open; 2021 Mar; 11(3):e041512. PubMed ID: 33674367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a six-methylation-marker assay on self-collected cervical samples - A feasibility study.
    Klischke L; von Ehr J; Kohls F; Kampers J; Hülse F; Schmitz M; Hennig A; Dörk T; Hillemanns P; Jentschke M
    J Virol Methods; 2021 Sep; 295():114219. PubMed ID: 34175345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
    Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
    BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    Solnæs JV; Njor SH; Tranberg M
    BMC Womens Health; 2023 Feb; 23(1):78. PubMed ID: 36823528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
    Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
    Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.